Tania Ivens

951 total citations
14 papers, 772 citations indexed

About

Tania Ivens is a scholar working on Infectious Diseases, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Tania Ivens has authored 14 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Virology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Tania Ivens's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and Mosquito-borne diseases and control (4 papers). Tania Ivens is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and Mosquito-borne diseases and control (4 papers). Tania Ivens collaborates with scholars based in Belgium, Slovakia and Philippines. Tania Ivens's co-authors include Kurt Hertogs, Christel Van den Eynde, Rudi Pauwels, Stuart Bloor, Sharon D. Kemp, Hilde Azijn, Marie‐Pierre de Béthune, Marcus A. Conant, Brendan Larder and Veronica Miller and has published in prestigious journals such as Cancer Research, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tania Ivens

14 papers receiving 742 citations

Peers

Countries citing papers authored by Tania Ivens

Since Specialization

Citations

This map shows the geographic impact of Tania Ivens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tania Ivens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tania Ivens more than expected).

Fields of papers citing papers by Tania Ivens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tania Ivens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tania Ivens. The network helps show where Tania Ivens may publish in the future.

Co-authorship network of co-authors of Tania Ivens

This figure shows the co-authorship network connecting the top 25 collaborators of Tania Ivens. A scholar is included among the top collaborators of Tania Ivens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tania Ivens. Tania Ivens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	An Automated Time-of-Drug-Addition Assay to Routinely Determine the Mode of Action of HIV-1 Inhibitors 2013 ·Assay and Drug Development Technologies ·Marnix Van Loock, Christel Van den Eynde, (unknown), Peggy Geluykens, Tania Ivens, (unknown), (unknown), (unknown), (unknown), (unknown)	7
2	Development of a High-Throughput Antiviral Assay for Screening Inhibitors of Chikungunya Virus and Generation of Drug-Resistant Mutations in Cultured Cells 2013 ·Methods in molecular biology ·(unknown), Jean‐François Bonfanti, Tania Ivens, (unknown), (unknown), Guenter Kraus	4
3	Cell-Based Antiviral Assays for Screening and Profiling Inhibitors Against Dengue Virus 2013 ·Methods in molecular biology ·(unknown), (unknown), Tania Ivens, (unknown), Kenny Simmen, Guenter Kraus	3
4	Identification of HIV-1 Reverse Transcriptase Inhibitors Using a Scintillation Proximity Assay 2013 ·Methods in molecular biology ·(unknown), Marnix Van Loock, Tania Ivens, Pascale Dehertogh, Dirk Jochmans, (unknown)	1
5	Abstract 4213: BRAF V600 mutation testing on FFPE samples using a novel fully integrated molecular diagnostics platform: A concordance study with reference methods. 2013 ·Cancer Research ·Benoit Devogelaere, (unknown), (unknown), (unknown), Tania Ivens, Bart Claes, Evelien Rondelez, (unknown), (unknown), Mark Kockx, Isabelle Vanden Bempt, Ina Vandenbroucke, Geert Maertens, Erwin Sablon	1
6	Expression and Purification of Dengue Virus NS5 Polymerase and Development of a High-Throughput Enzymatic Assay for Screening Inhibitors of Dengue Polymerase 2013 ·Methods in molecular biology ·(unknown), (unknown), Tania Ivens, (unknown), Katrien Vermeiren, (unknown), Benoit Devogelaere, (unknown), Guenter Kraus	14
7	In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435 2010 ·Antimicrobial Agents and Chemotherapy ·Oliver Lenz, Thierry Verbinnen, Tse‐I Lin, Leen Vijgen, Maxwell D. Cummings, Jimmy Lindberg, Jan Martin Berke, Pascale Dehertogh, Els Fransen, Annick Scholliers, Katrien Vermeiren, Tania Ivens, Pierre Raboisson, Michael Edlund, (unknown), Lotta Vrang, Herman de Kock, Gregory Fanning, Kenneth Simmen	178
8	Development of robust antiviral assays for profiling compounds against a panel of positive-strand RNA viruses using ATP/luminescence readout 2008 ·Journal of Virological Methods ·(unknown), Tania Ivens, Christel Van den Eynde, Sabine Hallenberger, Kurt Hertogs	12
9	1,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside Inhibitors 2008 ·Antimicrobial Agents and Chemotherapy ·Origène Nyanguile, Frederik Pauwels, (unknown), Carlo Boutton, (unknown), Tania Ivens, Liesbet van der Helm, (unknown), Wendy Mostmans, Frédéric Delouvroy, Pascale Dehertogh, Maxwell D. Cummings, (unknown), Kenneth Simmen, Pierre Raboisson	37
10	Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of Action 2006 ·Journal of Virology ·Dirk Jochmans, Jérôme Deval, Bart Kesteleyn, Herwig Van Marck, (unknown), (unknown), Pascale Dehertogh, Tania Ivens, Marcia Van Ginderen, (unknown), Maryam Ehteshami, Piet Wigerinck, Matthias Götte, Kurt Hertogs	77
11	Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirus 2005 ·Journal of Virological Methods ·Tania Ivens, Christel Van den Eynde, (unknown), (unknown), (unknown), (unknown), Åsa Öhagen, Rudi Pauwels, Kurt Hertogs	25
12	A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs 1998 ·Antimicrobial Agents and Chemotherapy ·Kurt Hertogs, Marie‐Pierre de Béthune, Veronica Miller, Tania Ivens, (unknown), (unknown), Christel Van den Eynde, (unknown), Hilde Azijn, Margriet Van Houtte, (unknown), Schlomo Staszewski, Marcus A. Conant, Stuart Bloor, Sharon D. Kemp, Brendan Larder, Rudi Pauwels	338
13	Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes 1997 ·Journal of Virological Methods ·(unknown), Katrien Fransen, (unknown), Wouter Janssens, Leo Heyndríckx, Tania Ivens, Katleen Vereecken, (unknown), (unknown), Guido van der Groen	41
14	Genetic Variability of HIV Type 1 in Kenya 1994 ·AIDS Research and Human Retroviruses ·Wouter Janssens, Leo Heyndríckx, Karin Fransén, M Temmerman, (unknown), Tania Ivens, J. Motte, Peter Piot, Guido van der Groen	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact